Laboratory-acquired vaccinia infection

Journal of Clinical Virology

Volumn 29, Issue 3, 2004, Pages 167-170

  Wlodaver, Clifford G ^a   Palumbo, Gregory J ^b   Waner, Joseph L ^b,c  

^a Univ of OK Health Sciences Center ^*  (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c Children's Hospital Oklahoma City   (United States)

Author keywords

Generalized vaccinia; Laboratory acquired infection; Vaccinia virus

Indexed keywords

CEFALEXIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACCIDENT; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CELL CULTURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ELECTRON MICROSCOPY; FEMALE; FEVER; HUMAN; IMMUNOFLUORESCENCE TEST; LABORATORY INFECTION; LABORATORY TEST; LYMPHADENOPATHY; MALAISE; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; PATIENT; PHYSICAL EXAMINATION; POXVIRUS; PRIORITY JOURNAL; PUS; VACCINIA; VIRUS PARTICLE; WORKPLACE;

EID: 1042298852     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(03)00118-5     Document Type: Article

References (15)

1. Binns M.M., Smith G.L. Recombinant poxviruses. 1992;235-267 CRC Press, Boca Raton, FL.
2. Buller R.M.L., Palumbo G.J. Safety and attenuation of vaccinia virus. Binns M.M., Smith G.L. Recombinant poxviruses. 1992;235-267 CRC Press.
3. Casemore D.P., Emslie E.S., Whyler D.K. Cowpox in a child, acquired from a cat. Clin. Exp. Dermatol. 12:1987;286-287.
4. CDC, 2001. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccination: recommendation of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal Wkly Rep. 2001;50 (RR-10):1-22.
5. Henderson D.A., Inglesby T.V., Bartlett J.G., et al. Smallpox as biological weapon: medical and public health management. JAMA. 281:1999;2127-2137.
6. Kesson A.M., Ferguson J.K., Rawlinison S.D., et al. Progressive vaccinia treated with ribavirin and vaccinia immune globulin. Clin. Infect. Dis. 25:1997;911-914.
7. Klingebiel T., Vallbracht A., Dollar G., et al. A severe human cowpox infection in south Germany. Pediatric Infect. Dis. J. 7:1988;883-885.
8. Lane J.M., Ruben F.L., Neff J.M., Millar J.D. Complications of smallpox vaccination:national survey in the United States. N. Engl. J. Med. 281:1969;1201-1208.
9. LeDuc J.W., Jahrling P.B. Strengthening national preparedness for smallpox: an update. Emerg. Infect. Dis. 7:2001;155-157.
10. Nakano J.H., Esposito J.J. Poxviruses. Schmidt N.J., Emmons R.W. Diagnostic procedures for Viral, Rickettsial, and Chlamydial infections. 6th ed. 1989;224-265 American Public Health Association, Washington, DC.
11. Neff J.M. Vaccinia virus (cowpox). Mandell G.G., Bennett J.E., Dolin R. Principles and practice of infectious diseases. 5th ed. 2000;1553-1555 Churchill Livingston.
12. Paoletti E. Applications of poxvirus vectors to vaccination: an update. Proc. Natl. Acad. Sci. USA. 93:1996;11349-11353.
13. Perry G.F. Occupational medicine forum. J. Occupat. Med. 34:1992;757.
14. Wenzel R.P., Nettleman M.D. Smallpox vaccination for investigators using vaccinia recombinants. Lancet. 2:(8663):1989;630-631.
15. Williams N.R., Cooper B.M. Counseling of workers handling vaccinia virus. Occup. Med. 43:1993;125-127.